Concepedia

Dawn M. Mampreian

DM

8

Publications

377

Citations

8

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Boston College

Dawn M. Mampreian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and biochemistry.

Top concepts

Publications per year

2004–2017

8

Publications

8

Enantioselective Synthesis of Nitroalkanes Bearing All-Carbon Quaternary Stereogenic Centers through Cu-Catalyzed Asymmetric Conjugate Additions

Jing Wu, Dawn M. Mampreian, Amir H. Hoveyda · Journal of the American Chemical Society · 2005 · 151 citations

Efficient Cu-Catalyzed Asymmetric Conjugate Additions of Alkylzinc Reagents to Aromatic and Aliphatic Acyclic Nitroalkenes

Dawn M. Mampreian, Amir H. Hoveyda · Organic Letters · 2004 · 78 citations

, , +11

SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Christopher L. Hamblett, Dawn M. Mampreian et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 44 citations · Full text

, , +10

The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors

Christopher L. Hamblett, Joey L. Methot, Dawn M. Mampreian et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 43 citations · Full text

, , +11

An unexpected aminocyclopropane reductive rearrangement

Joey L. Methot, Theresa A. Dunstan, Dawn M. Mampreian et al. · Tetrahedron Letters · 2007 · 17 citations

, , +1

Rows per page

1–5 of 8